Senate Appropriations Committee Chair Susan Collins (R-Maine) issued a letter on Tuesday to Office of Management and Budget (OMB) Director Russ Vought and NIH Director Francis Collins, expressing strong opposition to a proposed executive order. The order would shift authority over NIH scientific grants, effectively placing them under the direct political control of the White House.

Senator Collins argues that the current peer-review process, which relies on independent scientific experts to evaluate grant applications, is essential for maintaining the integrity and quality of medical research. By moving this oversight to the executive branch, critics fear that funding decisions could be influenced by political agendas rather than scientific merit or public health needs. The NIH currently manages billions of dollars in research funding, supporting projects ranging from cancer treatment to infectious disease prevention.

While the administration has not yet officially released the text of the executive order, the proposal has sparked a debate over the balance of power between political appointees and scientific institutions. Supporters of the move, though not explicitly quoted in the initial reports, generally argue that the executive branch should have more oversight over how taxpayer dollars are allocated. Conversely, Senator Collins and other opponents maintain that insulating the NIH from political pressure is a long-standing norm that protects the credibility of American scientific research. The situation remains fluid as the administration weighs whether to proceed with the directive despite the pushback from key congressional leaders.